PMC:7212965 / 5274-5491 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T17","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"een reported in 1%–36% of patients.10 An updated characterization of the GI and liver manifestations across global settings is needed to further inform clinical guidance in the management of patients with COVID-19.\n\nS"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T13","span":{"begin":80,"end":85},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"een reported in 1%–36% of patients.10 An updated characterization of the GI and liver manifestations across global settings is needed to further inform clinical guidance in the management of patients with COVID-19.\n\nS"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":205,"end":213},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"een reported in 1%–36% of patients.10 An updated characterization of the GI and liver manifestations across global settings is needed to further inform clinical guidance in the management of patients with COVID-19.\n\nS"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T43","span":{"begin":19,"end":21},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T44","span":{"begin":80,"end":85},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T45","span":{"begin":80,"end":85},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"een reported in 1%–36% of patients.10 An updated characterization of the GI and liver manifestations across global settings is needed to further inform clinical guidance in the management of patients with COVID-19.\n\nS"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":73,"end":75},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"}],"text":"een reported in 1%–36% of patients.10 An updated characterization of the GI and liver manifestations across global settings is needed to further inform clinical guidance in the management of patients with COVID-19.\n\nS"}

{"project":"LitCovid-PubTator","denotations":[{"id":"169","span":{"begin":73,"end":75},"obj":"Gene"},{"id":"173","span":{"begin":26,"end":34},"obj":"Species"},{"id":"174","span":{"begin":191,"end":199},"obj":"Species"},{"id":"191","span":{"begin":205,"end":213},"obj":"Disease"}],"attributes":[{"id":"A169","pred":"tao:has_database_id","subj":"169","obj":"Gene:2770"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"Tax:9606"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:9606"},{"id":"A191","pred":"tao:has_database_id","subj":"191","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"een reported in 1%–36% of patients.10 An updated characterization of the GI and liver manifestations across global settings is needed to further inform clinical guidance in the management of patients with COVID-19.\n\nS"}